Anna I Guerdjikova

Summary

Publications

  1. doi request reprint Binge eating disorder pharmacotherapy clinical trails--who is left out?
    Anna I Guerdjikova
    Department of Psychiatry, Lindner Center of HOPE, Mason, OH 45267 0559, USA
    Eur Eat Disord Rev 17:101-8. 2009
  2. doi request reprint A randomized, placebo-controlled study of zonisamide to prevent olanzapine-associated weight gain
    Susan L McElroy
    Lindner Center of HOPE, Mason, OH 45040, USA
    J Clin Psychopharmacol 32:165-72. 2012
  3. doi request reprint Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial
    Anna I Guerdjikova
    Department of Psychiatry, University of Cincinnati College of Medicine, Lindner Center of HOPE, Mason, Ohio 45040, USA
    Int Clin Psychopharmacol 24:150-8. 2009
  4. doi request reprint Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective study
    Susan L McElroy
    Research Institute, Lindner Center of HOPE, Mason, Ohio, USA
    Int J Eat Disord 44:262-8. 2011
  5. ncbi request reprint High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial
    Anna I Guerdjikova
    Division of Psychopharmacology Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
    Hum Psychopharmacol 23:1-11. 2008
  6. doi request reprint Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania
    Susan L McElroy
    4075 Old Western Row Road, Mason, OH 45040, USA
    J Clin Psychiatry 71:557-65. 2010
  7. doi request reprint Current pharmacotherapy options for bulimia nervosa and binge eating disorder
    Susan L McElroy
    Lindner Center of HOPE, 4075 Old Western Row Road, Mason, OH 45040, USA
    Expert Opin Pharmacother 13:2015-26. 2012
  8. doi request reprint Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial
    Anna I Guerdjikova
    Lindner Center of HOPE, Mason, OH, USA
    Int J Eat Disord 45:281-9. 2012
  9. ncbi request reprint Emotional eating and emotional eating alternatives in subjects undergoing bariatric surgery
    Anna I Guerdjikova
    Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267 0559, USA
    Obes Surg 17:1091-6. 2007
  10. ncbi request reprint Psychiatric and metabolic characteristics of childhood versus adult-onset obesity in patients seeking weight management
    Anna I Guerdjikova
    Psychopharmacology Program, Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267 0559, USA
    Eat Behav 8:266-76. 2007

Detail Information

Publications20

  1. doi request reprint Binge eating disorder pharmacotherapy clinical trails--who is left out?
    Anna I Guerdjikova
    Department of Psychiatry, Lindner Center of HOPE, Mason, OH 45267 0559, USA
    Eur Eat Disord Rev 17:101-8. 2009
    ..This report examined the characteristics of subjects interested in binge eating disorder (BED) pharmacotherapy trails who were ineligible for participation...
  2. doi request reprint A randomized, placebo-controlled study of zonisamide to prevent olanzapine-associated weight gain
    Susan L McElroy
    Lindner Center of HOPE, Mason, OH 45040, USA
    J Clin Psychopharmacol 32:165-72. 2012
    ..02). Zonisamide was effective for mitigating weight gain in patients with bipolar disorder or schizophrenia initiating treatment with olanzapine but was associated with cognitive impairment as an adverse event...
  3. doi request reprint Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial
    Anna I Guerdjikova
    Department of Psychiatry, University of Cincinnati College of Medicine, Lindner Center of HOPE, Mason, Ohio 45040, USA
    Int Clin Psychopharmacol 24:150-8. 2009
    ..As a result of an exceptionally high placebo response, it is likely that for efficacy measures except for body weight and metabolic indices, the study was incapable of detecting potentially clinically important drug-placebo difference...
  4. doi request reprint Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective study
    Susan L McElroy
    Research Institute, Lindner Center of HOPE, Mason, Ohio, USA
    Int J Eat Disord 44:262-8. 2011
    ..To assess preliminarily the effectiveness of sodium oxybate in binge eating disorder...
  5. ncbi request reprint High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial
    Anna I Guerdjikova
    Division of Psychopharmacology Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
    Hum Psychopharmacol 23:1-11. 2008
    ..The purpose of this study was to evaluate the efficacy and safety of high-dose escitalopram in the treatment of binge-eating disorder (BED) associated with obesity...
  6. doi request reprint Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania
    Susan L McElroy
    4075 Old Western Row Road, Mason, OH 45040, USA
    J Clin Psychiatry 71:557-65. 2010
    ..To determine whether divalproex extended release (ER) would be effective in outpatients with DSM-IV-TR-diagnosed ambulatory bipolar spectrum disorder (BSD) and moderate-to-severe hypomanic or mild manic symptoms (hypomania/mild mania)...
  7. doi request reprint Current pharmacotherapy options for bulimia nervosa and binge eating disorder
    Susan L McElroy
    Lindner Center of HOPE, 4075 Old Western Row Road, Mason, OH 45040, USA
    Expert Opin Pharmacother 13:2015-26. 2012
    ..Although psychotherapy may be effective, not all patients respond adequately...
  8. doi request reprint Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial
    Anna I Guerdjikova
    Lindner Center of HOPE, Mason, OH, USA
    Int J Eat Disord 45:281-9. 2012
    ..This study evaluated duloxetine in the treatment of binge eating disorder (BED) with comorbid current depressive disorders...
  9. ncbi request reprint Emotional eating and emotional eating alternatives in subjects undergoing bariatric surgery
    Anna I Guerdjikova
    Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267 0559, USA
    Obes Surg 17:1091-6. 2007
    ..The purpose of this study was to characterize emotional eating and its alternatives in obese patients undergoing bariatric surgery...
  10. ncbi request reprint Psychiatric and metabolic characteristics of childhood versus adult-onset obesity in patients seeking weight management
    Anna I Guerdjikova
    Psychopharmacology Program, Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267 0559, USA
    Eat Behav 8:266-76. 2007
    ..Early recognition and attention to eating and mood dysregulation, including, but not limited to binge eating disorder and bulimia nervosa, in some persons, might help reduce their lifetime risk for obesity...
  11. doi request reprint N-acetylcysteine in bulimia nervosa--open-label trial
    Anna I Guerdjikova
    Lindner Center of HOPE, Mason, OH 45040, USA
    Eat Behav 14:87-9. 2013
    ..In this trial, NAC was ineffective in BN and was associated with a high discontinuation rate...
  12. doi request reprint Binge eating disorder in elderly individuals
    Anna I Guerdjikova
    Lindner Center of HOPE, Mason, OH, USA
    Int J Eat Disord 45:905-8. 2012
    ..To preliminarily describe the clinical features of elderly individuals with binge eating disorder (BED)...
  13. doi request reprint Role of antiepileptic drugs in the management of eating disorders
    Susan L McElroy
    Lindner Center of HOPE, Mason, Ohio 45050, USA
    CNS Drugs 23:139-56. 2009
    ..g. mood) or neurological (e.g. seizure) disorder; otherwise, both agents, particularly valproate, are associated with weight gain. In conclusion, AEDs have an emerging role in the management of some eating disorders...
  14. doi request reprint Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial
    Susan L McElroy
    Lindner Center of HOPE, Research Institute, 4075 Old Western Row Road, Mason, OH45040, USA
    Int J Eat Disord 44:81-90. 2011
    ..To assess preliminarily the effectiveness of acamprosate in binge eating disorder (BED)...
  15. doi request reprint A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder
    Susan L McElroy
    Lindner Center of HOPE, Research Institute, Mason, OH 45040, USA
    Int J Eat Disord 46:239-45. 2013
    ..To assess preliminarily the effectiveness of a novel opioid antagonist, ALKS-33, in binge eating disorder (BED)...
  16. doi request reprint Zonisamide in the treatment of bulimia nervosa: an open-label, pilot, prospective study
    Anna I Guerdjikova
    Lindner Center of HOPE, Mason, Ohio Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio
    Int J Eat Disord 46:747-50. 2013
    ..To assess preliminarily the effectiveness of zonisamide in bulimia nervosa...
  17. ncbi request reprint Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial
    Susan L McElroy
    Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
    J Clin Psychiatry 67:1897-906. 2006
    ..Binge eating disorder (BED) is associated with obesity. Zonisamide is a novel antiepileptic drug associated with weight loss. The purpose of this study was to evaluate zonisa-mide in the treatment of BED associated with obesity...
  18. pmc Pharmacological management of binge eating disorder: current and emerging treatment options
    Susan L McElroy
    Lindner Center of HOPE, Mason, and Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    Ther Clin Risk Manag 8:219-41. 2012
    ..We conclude by summarizing these data, discussing the role of pharmacotherapy in the BED treatment armamentarium, and suggesting future areas for research...
  19. doi request reprint Bulimia nervosa presenting as rectal purging and rectal prolapse: case report and literature review
    Anna I Guerdjikova
    Lindner Center of HOPE, Mason, Ohio 45040, USA
    Int J Eat Disord 45:456-9. 2012
    ..Further research into the relationship between eating disorders, rectal purging, and gastrointestinal dysfunction is called for...
  20. ncbi request reprint Response of recurrent binge eating and weight gain to topiramate in patients with binge eating disorder after bariatric surgery
    Anna I Guerdjikova
    Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267 0559, USA
    Obes Surg 15:273-7. 2005
    ..The effectiveness of topiramate was evaluated in the treatment of recurrent binge eating and weight gain in patients with binge eating disorder (BED) and obesity who had undergone initially successful bariatric surgery...